Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Insomnia in Parkinson Disease
NCT02729714Phase 4Completed
- Start
- Apr 2016
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in Insomnia. Started Apr 2016; status: completed.
02
Drugs
suvorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02729714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729714.